Enlivex gains Israeli regulatory approval to commence TMJ osteoarthritis trial
Enlivex Therapeutics has gained approval from the Israeli Ministry of Health to commence a Phase I trial of Allocetra in individuals with temporomandibular joint (TMJ) osteoarthritis. The study, to be conducted by Sheba Medical Center’s Rheumatology Unit …